Bronchogen

Description

Bronchogen

Also known as: Ala-Glu-Asp-Leu, AEDL

Bronchogen is a peptide-based bioregulator sourced from animal respiratory tissue, developed within the field of peptide bioregulation research. It is primarily investigated for its potential to support bronchial tissue function, promote respiratory health, aid cellular regeneration, and maintain normal lung function. Due to its suggested influence on gene expression and tissue integrity in the respiratory system, Bronchogen is frequently referenced in studies related to anti-aging and organ-specific peptide therapies.

Areas of research and wellness interest typically include:
– Support for the respiratory system
– Maintenance of bronchial tissue health
– Studies on cellular regeneration
– Preservation of healthy lung function
– Advancement of peptide bioregulation science

• Status: Currently in preclinical research; approved in Russia as a dietary supplement. Evidence level: Preclinical.
• Common dosage: 10–20 mg per day, taken once or twice daily, available in oral capsule or sublingual form.
• Investigated for: Supporting respiratory health, chronic obstructive pulmonary disease (COPD), improving lung function, and managing bronchitis.